5O07

The crystal structure of the human carbonic anhydrase II in complex with a nitroimidazole sulfamate inhibitor

5O07 の概要

• エントリーDOI: 10.2210/pdb5o07/pdb
• 分子名称: Carbonic anhydrase 2, ZINC ION, 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl sulfamate, ... (4 entities in total)
• 機能のキーワード: sulfamate, zinc binding, lyase-lyase inhibitor complex, nitroimidazole, lyase
• 由来する生物種: Homo sapiens (Human)
• 細胞内の位置: Cytoplasm : P00918
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 29604.70

構造登録者

Alterio, V.,De Simone, G.,Esposito, D. (登録日: 2017-05-16, 公開日: 2017-08-02, 最終更新日: 2024-01-17)

主引用文献

De Simone, G.,Langella, E.,Esposito, D.,Supuran, C.T.,Monti, S.M.,Winum, J.Y.,Alterio, V.
Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations.
J Enzyme Inhib Med Chem, 32:1002-1011, 2017

PubMed Abstract: Sulphamate and sulphamide derivatives have been largely investigated as carbonic anhydrase inhibitors (CAIs) by means of different experimental techniques. However, the structural determinants responsible for their different binding mode to the enzyme active site were not clearly defined so far. In this paper, we report the X-ray crystal structure of hCA II in complex with a sulphamate inhibitor incorporating a nitroimidazole moiety. The comparison with the structure of hCA II in complex with its sulphamide analogue revealed that the two inhibitors adopt a completely different binding mode within the hCA II active site. Starting from these results, we performed a theoretical study on sulphamate and sulphamide derivatives, demonstrating that electrostatic interactions with residues within the enzyme active site play a key role in determining their binding conformation. These findings open new perspectives in the design of effective CAIs using the sulphamate and sulphamide zinc binding groups as lead compounds.

PubMed: 28738704
DOI: 10.1080/14756366.2017.1349764

実験手法

X-RAY DIFFRACTION (1.8 Å)